Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Glioma × Cognitive Behavioral Therapy × Clear all

Phase

Phase NA 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sleep Initiation and Maintenance Disorders 27 Neoplasms 19 Breast Neoplasms 17 Depression 9 Anxiety Disorders 8 Prostatic Neoplasms 6 Lung Neoplasms 5 Fatigue 5 Motor Activity 4 Weight Loss 3 Melanoma 3 Chronic Pain 3 Smoking Cessation 2 Sleep Wake Disorders 2 Pain 2 Overweight 2 Obesity 2 Nervous System Diseases 2 Multiple Myeloma 2 Lymphoma 2 Cognitive Dysfunction 2 Carcinoma, Non-Small-Cell Lung 2 Weight Gain 1 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Tobacco Use Disorder 1 Substance-Related Disorders 1 Stress, Psychological 1 Squamous Cell Carcinoma of Head and Neck 1 Smoking 1

Interventions

Magnetic Resonance Spectroscopy 15 Blood Specimen Collection 7 Temozolomide 5 Yoga 3 Radiotherapy, Intensity-Modulated 3 Magnetic Resonance Imaging 3 Biopsy 3 Bevacizumab 3 Transcranial Magnetic Stimulation 2 Surveys and Questionnaires 2 Restraint, Physical 2 Radiosurgery 2 Radiation 2 Psychosocial Intervention 2 Proton Therapy 2 Physical Therapy Modalities 2 Palliative Care 2 Mind-Body Therapies 2 Mental Status and Dementia Tests 2 Heart Rate 2 Gadolinium DTPA 2 Exercise 2 Elasticity Imaging Techniques 2 Drug Therapy 2 Diffusion Tensor Imaging 2 Congresses as Topic 2 Aminolevulinic Acid 2 poly ICLC 1 pembrolizumab 1 gallium Ga 68 dotatate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06468176 2025-12-19

FREEDOME

Institut du Cancer de Montpellier - Val d'Aurelle

Phase NA Recruiting

Glioma, Neoplasms, Nervous System Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡